Rafael Fonseca

Operates medical clinics and hospitals

Provides cancer treatment services

Engages in research, education, communication and collaboration to prevent and cure cancer

Operates as a hematology membership organisation

Operates medical hospitals

Functions as a College/University

Operates as a biopharmaceutical company which develops and commercializes hematologic malignancies therapies

The International Myeloma Society is a professional, scientific, and medical organization dedicated to advancing research, education, and clinical care related to multiple myeloma and plasma cell disorders. The private company is based in Rochester. The society brings together basic scientists, clinical investigators, physicians, and healthcare practitioners worldwide to promote collaboration and knowledge exchange through workshops, conferences, symposia, and educational events. It provides membership benefits such as access to meeting materials, member directories, and newsletters, and supports the myeloma community by funding translational and career development research awards. The society addresses disparities in treatment access through programs like the Therapeutic Map, which offers region-specific drug availability guidelines for clinicians. It organizes annual meetings and thematic sessions with expert talks and collaborative discussions with regulatory agencies, focusing on topics such as genomics and novel therapies.